Urology Today.net

Site updated at Thursday, 12 May 2016

Common Urological Problems

Vytorin

FDA fails to approve cholesterol drug for kidney disease

U.S. health regulators amended the prescribing label for Merck & Co’s cholesterol-lowering drug Vytorin to show it prevents heart problems in patients with chronic kidney disease, but stopped short of approving its use for that purpose.

The decision means Merck cannot market Vytorin as a treatment for reducing the rate of heart problems in… FDA fails to approve cholesterol drug for kidney disease   



hla-b antigens1 - heart dysfunction1 - harvard school of public health2 - journal of rheumatology1 - posterior urethra1 - cihi1 - osteomalacia2 - end stage kidney disease1 - urinary tract infection7 - stone recurrence1 - urethrotomy1 - secondary tumor1 - prostate treatment2 - robotic-assisted operations1 - genetic changes1 - renal fibrosis1 - national ambulatory medical care survey1 - coccyx1 - urethral sphincter2 - standard therapy1 - renal capsule1 - urinary tract infections8 - prostate cancer cells2 - prostate tumor1 - pubis2 - protein in the urine2 - coronary artery bypass surgery1 - kidney tumors1 - risk of prostate cancer2 - achilles tendon1 -